These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 5598529)
1. [Opipramol (insidon). II. A method for its quantitative determination in blood]. Skov F Ugeskr Laeger; 1967 Aug; 129(34):1083-5. PubMed ID: 5598529 [No Abstract] [Full Text] [Related]
2. [Opipramol in human milk?]. Herrmann B; von Kobyletzki D Med Welt; 1970 Feb; 7():267-9. PubMed ID: 5444226 [No Abstract] [Full Text] [Related]
4. [Elaboration of the method of detection and determination of neurotropic drugs in the blood of persons driving motor vehicles]. Kaniewska T Acta Pol Pharm; 1981; 38(2):217-22. PubMed ID: 7315465 [No Abstract] [Full Text] [Related]
5. [Preliminary studies on the determination of the optimal opipramol dosage in depression]. Kanarkowski R; Wichliński L; Targońska A Psychiatr Pol; 1979; 13(3):235-41. PubMed ID: 382215 [No Abstract] [Full Text] [Related]
6. Chromatographic analysis (TLC) of fluoxetine, doxepine, imipramine and opipramol in human plasma. Misztal G; Hopkała H; Sławik T Acta Pol Pharm; 1997; 54(4):257-9. PubMed ID: 9511452 [TBL] [Abstract][Full Text] [Related]
8. [The detection of opipramol (insidon) and nortriptyline (nortrilen) in urine]. Drabner J; Bauer H; Schwerd W Arch Toxikol; 1966; 21(6):367-72. PubMed ID: 5989895 [No Abstract] [Full Text] [Related]
9. [Treatment of menopausal discomfort with opipramol (Insidon)]. Andersen A; Andersen HJ Nord Psykiatr Tidsskr; 1968; 22(4):353-7. PubMed ID: 5710605 [No Abstract] [Full Text] [Related]
10. [APROPOS OF THE USE OF G.330-40 (INSIDON) IN CURRENT PSYCHIATRIC PRACTICE]. VERCEL R; ARROU-VIGNOD JL Ann Med Psychol (Paris); 1964 Apr; 122():638-44. PubMed ID: 14145287 [No Abstract] [Full Text] [Related]
12. [Pharmacokinetics and relative bioavailability of opipramol in the new INSIDON--sustained release preparation]. Nilsson EB; Rimmele SM; Schmidt EK; Antonin KH; Bieck PR Fortschr Neurol Psychiatr; 1998 Dec; 66 Suppl 1():S13-6. PubMed ID: 9922921 [No Abstract] [Full Text] [Related]
13. [EXPERIENCES WITH INSIDON IN GENERAL PRACTICE]. TREURNIET WA Geneeskd Gids; 1963 Aug; 41():341-4. PubMed ID: 14084740 [No Abstract] [Full Text] [Related]
14. [Opipramol (insidon). I. A review on pharmacology, indications and side effects]. Skov F Ugeskr Laeger; 1967 Aug; 129(34):1079-83. PubMed ID: 4877209 [No Abstract] [Full Text] [Related]
15. [EXPERIENCE WITH THE USE OF A NEW DRUG, INSIDON IN THE CLIMACTERIC]. ISHIGAMI O; MIZUSAWA S; WASHIO T Sanfujinka Chiryo; 1964 May; 8():625-7. PubMed ID: 14194014 [No Abstract] [Full Text] [Related]
16. [THE TREATMENT OF PSYCHOVEGETATIVE DISORDERS WITH INSIDON]. WAGNER H Wien Med Wochenschr; 1964 May; 114():384-6. PubMed ID: 14213862 [No Abstract] [Full Text] [Related]
17. [EFFECTS OF INSIDON ON ASTHENOPIA IN PSYCHONEUROTICS]. MATSUSHITA K; TANI Y Rinsho Ganka; 1963; 17():514-8. PubMed ID: 14130619 [No Abstract] [Full Text] [Related]
18. [INSIDON TREATMENT OF SEVERE WITHDRAWAL SYMPTOMS IN ALCOHOLICS]. TURUNEN S Duodecim; 1963; 79():759-62. PubMed ID: 14056974 [No Abstract] [Full Text] [Related]
19. [CONCERNING THE EFFECTS OF A NEW IMINO-STILBENE DERIVATIVE (INSIDON) IN CANCER IN THE COURSE OF RADIOTHERAPY TREATMENT]. TETTONI E; SINISTRERO G Minerva Med; 1963 Dec; 54():3898-900. PubMed ID: 14121446 [No Abstract] [Full Text] [Related]